Beryl Capital Management’s Checkpoint Therapeutics CKPT Stock Holding History

Beryl Capital Management’s Portfolio CKPT Stock Details CKPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-6,074,216	Closed	-$24.5M	–	29
2025 Q1	$24.5M	Buy	+6,074,216	New	+$20.2M	9.17%	4

Beryl Capital Management's CKPT Position: Q2 2025 in Review

Beryl Capital Management sold out of Checkpoint Therapeutics (CKPT) in Q2 2025, closing a stake of 6,074,216 shares — an estimated $24.5M sold.

Beryl Capital Management first reported a position in CKPT in Q1 2025 and held it in 1 quarter. The position peaked at $24.5M in Q1 2025. 0 funds tracked by Wall St. Rank hold CKPT as of Q2 2025.

Beryl Capital Management reported no remaining Checkpoint Therapeutics position as of Q2 2025 after selling out during the quarter.
Beryl Capital Management sold 6,074,216 Checkpoint Therapeutics shares in Q2 2025, an estimated $24.5M.
Beryl Capital Management first reported a position in Checkpoint Therapeutics in Q1 2025 and held it in 1 quarter.
Beryl Capital Management's Checkpoint Therapeutics position peaked at $24.5M in Q1 2025.
0 funds tracked by Wall St. Rank held Checkpoint Therapeutics as of Q2 2025.

Based on Beryl Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.